Weight Loss Medications for Patients with Normal BMI

Indications for Weight Loss Medications

• The American Academy of Family Physicians recommends that weight loss medications should not be prescribed to patients with normal BMI, as they are only indicated for patients with BMI ≥30 kg/m² or BMI ≥27 kg/m² with weight-related comorbidities 1, 2
• Weight loss pharmacotherapy is specifically indicated for patients with BMI ≥30 kg/m² (obesity) 3, 4, 1
• Weight loss pharmacotherapy is also indicated for patients with BMI ≥27 kg/m² with weight-related comorbidities such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea 1, 2
• Patients who have failed to achieve weight loss goals through diet and exercise alone may be considered for weight loss medications 3, 5

FDA-Approved Weight Loss Medications and Their Indications

• Orlistat is indicated for use in adults with BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities, according to the American Gastroenterological Association 4, 6
• Phentermine/topiramate is indicated for patients with BMI ≥30 kg/m² or ≥27 kg/m² with at least one weight-related comorbidity, as recommended by the American College of Gastroenterology 2
• Naltrexone/bupropion is indicated for adults with BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities, according to the American College of Gastroenterology 4, 7

Risks vs. Benefits

• The American College of Physicians notes that all weight loss medications have side effects that may not be justified in normal-weight individuals, presenting an unfavorable risk-benefit ratio 3, 5, 4
• Orlistat may cause GI side effects and fat-soluble vitamin deficiencies, as reported by the American Gastroenterological Association 4, 8
• Phentermine/topiramate may cause teratogenicity and cognitive impairment, according to the American College of Gastroenterology 2
• Naltrexone/bupropion may cause seizure risk and blood pressure elevation, as reported by the American College of Gastroenterology 4, 7

Clinical Approach to Weight Management

• The American Academy of Family Physicians recommends focusing on healthy lifestyle modifications rather than medication for patients with normal BMI who express concerns about weight 3, 1
• Patients with normal BMI who express concerns about weight should be evaluated for other causes of weight concerns, such as body composition issues rather than total weight, as recommended by the American Academy of Family Physicians 1

Common Pitfalls to Avoid

• The American Academy of Family Physicians advises against prescribing weight loss medications based solely on patient request without appropriate BMI criteria 1
• Weight loss from medications is typically temporary and weight regain occurs when medications are discontinued, as reported by the American College of Physicians 5